Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.
NNIT A/S is a Danish public IT company that provides IT consultancy, development, implementation and outsourcing of IT services to clients within life sciences in Denmark and internationally as well as to all types of customers in Denmark.
Chr. Hansen A/S is a bioscience company based in Hørsholm, Denmark. Since January 2024 together with Novozymes a part of Novonesis. The company is a supplier of bacteria cultures, probiotics, enzymes and human milk oligosaccharides. Its products are used in the production of fresh dairy, cheese, meat, seafood, fermented beverages, dairy and meat alternatives, dietary supplements, infant formula, pharmaceuticals and agricultural products. In 2021, Chr. Hansen A/S was ranked 1st on FoodTalks' Top 30 Global Probiotic Food Ingredient Companies list. Chr. Hansen owns one of the world's largest commercial bacteria collections.
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Medicon Valley is a leading international life-sciences cluster in Europe, spanning the Greater Copenhagen region of eastern Denmark and southern Sweden. It is one of Europe's strongest life science clusters, with many life science companies and research institutions located within a relatively small geographical area. The name has officially been in use since 1997.
Smørumnedre is a town and suburban area situated in Egedal Municipality in the northwestern outskirts of Copenhagen, Denmark and forms part of Copenhagen's urban area. The original village has merged with the neighbouring villages of Måløv in Ballerup Municipality and Jonstrup in Furesø Municipality to form an urban agglomeration with a population of 21,353. The small and relatively undisturbed village of Smørumovre is located about 500 metres to the west of Smørumnedre while Lille Smørum("Little Smørum") refers to a group of scattered farms to the south. The three localities are collectively referred to as Smørum.
The Villum Foundation ; formerly Villum Kann Rasmussen Foundation was set up in 1971 by civil engineer Villum Kann Rasmussen (1909–1993). 10 years later, he set up the Velux Foundation. Rasmussen was the founder of VELUX and Velfac, Danish window companies. Both foundations are part of VKR Holding A/S, owned by the Rasmussen family and the Villum Foundation, which is the main shareholder.
Hans Christian Hagedorn was the creator of NPH insulin and the founder of Nordisk Insulinlaboratorium, which is known today as Novo Nordisk.
Novo Holdings A/S is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion. Danish Kroner and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore.
Lise Kingo is a Danish businesswoman who currently serves as Independent Board Director at Danone, Sanofi and Covestro. Kingo is also a member of the Advisory Board for Humanitarian and Development Aid at the Novo Nordisk Foundation.
Yihai Cao, M.D., hM. D., Ph.D., is a Chinese-born Swedish scientist and a professor at the Karolinska Institute, Sweden. He is also an honorary professor/guest professor in Copenhagen University, Denmark; Linköping University, Sweden; Leicester University, UK; Shinshu University, Japan; Shandong University, China; and Peking University, China. He is an internationally recognized and cited researcher in cancer, obesity, diabetes, cardiovascular disease, and eye disease research. His publications have been cited more than 35,000 times and his h-index is 92. Cao received the Fernström research prize, the Karolinska distinguished professor award, and the Axel Hirsch Prize in medicine. Cao received an ERC-advanced research grant award, and a Novo Nordisk-advanced grant award. From 2018, Cao was elected to Academia Europaea, the European Academy of Sciences and Arts, the Chinese Academy of Engineering, the National Academy of Inventors, and The World Academy of Sciences. His research findings received broad public attentions including New York Times, Reuters and Swedish National TV broad casting.
Kasim Kutay is a British fund manager who is the CEO of Danish Novo Holdings A/S, an investment fund that manages investments and assets for the Novo Nordisk Foundation. He holds British citizenship and resides in Denmark.
Ole Kiehn is a Danish-Swedish neuroscientist. He is Professor of Integrative Neuroscience at the Department of Neuroscience, University of Copenhagen, Denmark, and professor of neurophysiology at Karolinska Institute, Sweden.
Drew Weissman is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Lars Rebien Sørensen is a Danish businessman and former CEO of the pharmaceutical company Novo Nordisk and current chairman of the board at the Novo Nordisk Foundation and Novo Holdings A/S.
Mads Krogsgaard Thomsen is a Danish businessman, CEO of the Novo Nordisk Foundation and former Executive Vice President of Research & Development, head of R&D and Chief Scientific Officer (CSO) at the pharmaceutical company Novo Nordisk.
The Novo Nordisk Prize is an annual award presented to acknowledge exceptional contributions within the fields of medical and health sciences. It is specifically aimed at individuals who have demonstrated outstanding research or innovation that has the potential to advance medical science, particularly in areas related to diabetes, endocrinology, and biopharmaceutical science. The prize is administered by the Novo Nordisk Foundation, an independent Danish foundation with a broad commitment to scientific research and humanitarian objectives.
The Novozymes Prize is an annual scientific award. The prize aims to recognise outstanding contributions to the advancement of science within the fields of biotechnology and bioinnovation.
The Hagedorn Prize is an annual award within the field of medical research, specifically recognizing outstanding contributions to diabetes research and endocrinology. Named after Hans Christian Hagedorn, a renowned Danish scientist and co-founder of Nordisk Insulinlaboratorium, the prize celebrates achievements in the understanding and treatment of diabetes.
The Jacobaeus Prize, (also known as the "Jacobæus Prize") is regarded as a prestigious recognition within the field of medical research. It is an annual award given to individuals who have made significant contributions to the advancement of medical science, particularly in the areas of physiology or endocrinology.
